Abstract
Background
The diagnosis of subungual melanoma (SUM) can be challenging and SUMs generally have a worse prognosis than melanomas arising elsewhere. Due to their rarity, the evidence to guide management is limited. This study sought to identify clinicopathological features predictive of outcome and to provide guidelines for management.
Methods
From a large, single-institution database, 103 patients with in situ (n = 9) or invasive (n = 94) SUMs of the hand treated between 1953 and 2014 were identified and their features analyzed.
Results
The most common site of hand SUMs was the thumb (53%). Median tumor thickness was 3.1 mm, and SUMs were commonly of the acral subtype (57%), ulcerated (58%), amelanotic (32%), and had mitoses (73%). Twenty-one patients reported prior trauma to the tumor site. Twenty-two patients were stage III at diagnosis; 7 underwent therapeutic lymph node dissection and 22 underwent elective lymph node dissection (5 positive), while 36 had sentinel node biopsy (SNB), 28% of which were positive. Forty percent of SNB-positive patients had involved non-sentinel nodes (SNs) in their completion lymph node dissection. Five-year melanoma-specific survival (MSS) and disease-free survival (DFS) rates were 70% and 52%, respectively. On multivariate analysis, regional node metastasis and right-hand tumor location were significant predictors of shorter DFS and MSS, whereas mitoses negatively impacted DFS only and increasing Breslow thickness impacted MSS only.
Conclusions
This study confirms that SUMs on the hand usually present at an advanced stage. Distal amputation appears safe for invasive SUMs, and SNB should be considered as these patients have a high risk of both SN and non-SN metastasis.
Similar content being viewed by others
References
Lyle M, Haydu LE, Menzies AM, et al. The molecular profile of metastatic melanoma in Australia. Pathology 2016; 48:188–93.
Hayward NK, Wilmott JS, Waddell N, et al. Whole-genome landscapes of major melanoma subtypes. Nature 2017; 545:175–180.
Banfield CC, Redburn JC, Dawber RP. The incidence and prognosis of nail apparatus melanoma. A retrospective study of 105 patients in four English regions. Br J Dermatol 1998; 139:276–9.
Kato T, Suetake T, Sugiyama Y, et al. Epidemiology and prognosis of subungual melanoma in 34 Japanese patients. Br J Dermatol 1996; 134:383–7.
Banfield CC, Dawber RP. Nail melanoma: a review of the literature with recommendations to improve patient management. Br J Dermatol 1999; 141:628–32.
Parker SG, Diffey BL. The transmission of optical radiation through human nails. Br J Dermatol 1983; 108:11–6.
Rawson RV, Johansson PA, Hayward NK, et al. Unexpected UVR and non-UVR mutation burden in some acral and cutaneous melanomas. Lab Invest 2017; 97:130–145.
Quinn MJ, Thompson JF, Crotty K, et al. Subungual melanoma of the hand. J Hand Surg Am 1996; 21:506–11.
Rigby HS, Briggs JC. Subungual melanoma: a clinico-pathological study of 24 cases. Br J Plast Surg 1992; 45:275–8.
Cochran AM, Buchanan PJ, Bueno RA Jr, et al. Subungual melanoma: a review of current treatment. Plast Reconstr Surg 2014; 134:259–73.
Gershenwald JE, Scolyer RA, Hess KR, et al. Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer Eighth Edition cancer staging manual. CA Cancer J Clin 2017; 67:472–92.
Koops HS, Vaglini M, Suciu S, et al. Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593. J Clin Oncol 1998; 16:2906–12.
Durbec F, Martin L, Derancourt C, et al. Melanoma of the hand and foot: epidemiological, prognostic and genetic features. A systematic review. Br J Dermatol 2012; 166:727–39.
Hwang K, Han JY, Lee SI. Multiple malignant melanomas at different burn scar areas: a case report. Dermatol Surg 2004; 30:562–5.
Roberts AH. Subungual melanoma following a single injury. J Hand Surg Br 1984; 9:328–30.
Stevens A, Spooner D. Malignant melanoma occurring within a previously irradiated area. Clin Oncol (R Coll Radiol) 1999; 11:426–8.
Green A, McCredie M, MacKie R, et al. A case-control study of melanomas of the soles and palms (Australia and Scotland). Cancer Causes Control 1999; 10:21–5.
Dal’Forno T, Cartell A, Bakos L. Dermabrasion in acquired melanocytic nevi: a histopathological and immunohistochemical study. Am J Dermatopathol 2011; 33:40–6.
Sladden MJ, Balch C, Barzilai DA, et al. Surgical excision margins for primary cutaneous melanoma. Cochrane Database Syst Rev 2009;(4):CD004835.
Dasgupta T, Brasfield R. Subungual Melanoma: 25-Year Review of Cases. Ann Surg 1965; 161:545–52.
Nguyen JT, Bakri K, Nguyen EC, et al. Surgical management of subungual melanoma: mayo clinic experience of 124 cases. Ann Plast Surg 2013; 71:346–54.
Tamurian RM, Gutow AP. Amputations of the hand and upper extremity in the management of malignant tumors. Hand Clin 2004; 20:vi, 213–20.
Blessing K, Kernohan NM, Park KG. Subungual malignant melanoma: clinicopathological features of 100 cases. Histopathology 1991; 19:425–9.
Cohen T, Busam KJ, Patel A, et al. Subungual melanoma: management considerations. Am J Surg 2008; 195:244–8.
O’Leary JA, Berend KR, Johnson JL, et al. Subungual melanoma. A review of 93 cases with identification of prognostic variables. Clin Orthop Relat Res 2000; 378:206–12.
Duarte AF, Correia O, Barros AM, et al. Nail matrix melanoma in situ: conservative surgical management. Dermatology 2010; 220:173–5.
Ogata D, Uhara H, Tsutsumida A, et al. Nail apparatus melanoma in a Japanese population: a comparative study of surgical procedures and prognoses in a large series of 151 cases. Eur J Dermatol 2017; 27:620–6.
Kim JY, Jung HJ, Lee WJ, et al. Is the distance enough to eradicate in situ or early invasive subungual melanoma by wide local excision from the point of view of matrix-to-bone distance for safe inferior surgical margin in Koreans. Dermatology 2011; 223:122–3.
Rousseau DL Jr, Ross MI, Johnson MM, et al. Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients. Ann Surg Oncol 2003; 10:569–74.
Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med 2014; 370:599–609.
Bello DM, Chou JF, Panageas KS, et al. Prognosis of acral melanoma: a series of 281 patients. Ann Surg Oncol 2013; 20:3618–25.
Curtin JA, Busam K, Pinkel D, et al. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 2006; 24:4340–6.
Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med 2005; 353:2135–47.
Acknowledgment
The authors wish to thank The Dagmar Marshall Foundation and The Danish Cancer Society for financial research support for Annette Chakera to finalize this study. Assistance from colleagues at Melanoma Institute Australia and Royal Prince Alfred Hospital is also gratefully acknowledged. RAS is supported by an NHMRC Fellowship. JFT is supported by the Melanoma Foundation of the University of Sydney.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chakera, A.H., Quinn, M.J., Lo, S. et al. Subungual Melanoma of the Hand. Ann Surg Oncol 26, 1035–1043 (2019). https://doi.org/10.1245/s10434-018-07094-w
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-018-07094-w